Concepedia

Donna Holloway

DH

Statistics

Publications

13

Citations

3.8K

H-Index

12

Active since

1994

Affiliations

Amgen (United States)(Current)

IQVIA (United States)

Indiana University – Purdue University Indianapolis

Altoona Center for Clinical Research

Institut Jules Bordet

Donna Holloway is an author at Amgen (United States) specializing in bone metabolism, medicine, and bone health.

Publications per year

1994–2015

13

Publications

13

Denosumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, E. Michael Lewiecki, Stanley Cohen et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

, , +14

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

Pirow Bekker, Donna Holloway, Amy S Rasmussen et al. · Journal of Bone and Mineral Research · 2004 · 767 citations · Full text

, , +17

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Jean-Jacques Body, Thierry Façon, Robert E. Coleman et al. · Clinical Cancer Research · 2006 · 491 citations · Full text

, , +17

The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women

Pirow Bekker, Donna Holloway, Arline Nakanishi et al. · Journal of Bone and Mineral Research · 2001 · 490 citations · Full text

, , +15

A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Jean‐Jacques Body, Philip R. Greipp, Robert E. Coleman et al. · Cancer · 2003 · 381 citations · Full text

, , +17

1–5 of 13